Cargando…

Loss in MCL-1 function sensitizes non-Hodgkin's lymphoma cell lines to the BCL-2-selective inhibitor venetoclax (ABT-199)

Detalles Bibliográficos
Autores principales: Phillips, D C, Xiao, Y, Lam, L T, Litvinovich, E, Roberts-Rapp, L, Souers, A J, Leverson, J D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817096/
https://www.ncbi.nlm.nih.gov/pubmed/26967820
http://dx.doi.org/10.1038/bcj.2016.12
_version_ 1782424838857555968
author Phillips, D C
Xiao, Y
Lam, L T
Litvinovich, E
Roberts-Rapp, L
Souers, A J
Leverson, J D
author_facet Phillips, D C
Xiao, Y
Lam, L T
Litvinovich, E
Roberts-Rapp, L
Souers, A J
Leverson, J D
author_sort Phillips, D C
collection PubMed
description
format Online
Article
Text
id pubmed-4817096
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-48170962016-04-14 Loss in MCL-1 function sensitizes non-Hodgkin's lymphoma cell lines to the BCL-2-selective inhibitor venetoclax (ABT-199) Phillips, D C Xiao, Y Lam, L T Litvinovich, E Roberts-Rapp, L Souers, A J Leverson, J D Blood Cancer J Corrigendum Nature Publishing Group 2016-03 2016-03-11 /pmc/articles/PMC4817096/ /pubmed/26967820 http://dx.doi.org/10.1038/bcj.2016.12 Text en Copyright © 2016 Macmillan Publishers Limited
spellingShingle Corrigendum
Phillips, D C
Xiao, Y
Lam, L T
Litvinovich, E
Roberts-Rapp, L
Souers, A J
Leverson, J D
Loss in MCL-1 function sensitizes non-Hodgkin's lymphoma cell lines to the BCL-2-selective inhibitor venetoclax (ABT-199)
title Loss in MCL-1 function sensitizes non-Hodgkin's lymphoma cell lines to the BCL-2-selective inhibitor venetoclax (ABT-199)
title_full Loss in MCL-1 function sensitizes non-Hodgkin's lymphoma cell lines to the BCL-2-selective inhibitor venetoclax (ABT-199)
title_fullStr Loss in MCL-1 function sensitizes non-Hodgkin's lymphoma cell lines to the BCL-2-selective inhibitor venetoclax (ABT-199)
title_full_unstemmed Loss in MCL-1 function sensitizes non-Hodgkin's lymphoma cell lines to the BCL-2-selective inhibitor venetoclax (ABT-199)
title_short Loss in MCL-1 function sensitizes non-Hodgkin's lymphoma cell lines to the BCL-2-selective inhibitor venetoclax (ABT-199)
title_sort loss in mcl-1 function sensitizes non-hodgkin's lymphoma cell lines to the bcl-2-selective inhibitor venetoclax (abt-199)
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817096/
https://www.ncbi.nlm.nih.gov/pubmed/26967820
http://dx.doi.org/10.1038/bcj.2016.12
work_keys_str_mv AT phillipsdc lossinmcl1functionsensitizesnonhodgkinslymphomacelllinestothebcl2selectiveinhibitorvenetoclaxabt199
AT xiaoy lossinmcl1functionsensitizesnonhodgkinslymphomacelllinestothebcl2selectiveinhibitorvenetoclaxabt199
AT lamlt lossinmcl1functionsensitizesnonhodgkinslymphomacelllinestothebcl2selectiveinhibitorvenetoclaxabt199
AT litvinoviche lossinmcl1functionsensitizesnonhodgkinslymphomacelllinestothebcl2selectiveinhibitorvenetoclaxabt199
AT robertsrappl lossinmcl1functionsensitizesnonhodgkinslymphomacelllinestothebcl2selectiveinhibitorvenetoclaxabt199
AT souersaj lossinmcl1functionsensitizesnonhodgkinslymphomacelllinestothebcl2selectiveinhibitorvenetoclaxabt199
AT leversonjd lossinmcl1functionsensitizesnonhodgkinslymphomacelllinestothebcl2selectiveinhibitorvenetoclaxabt199